The impact of primary diseases is substantial, demanding advanced therapeutic options. Cellular therapies represent a especially exciting avenue, offering the chance to restore damaged liver tissue and improve therapeutic outcomes. Currently, research focuses on several approaches, including the administration of adult regenerative units directly i